Search Results for “” – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Project:Therapeutic drug monitoring

Categories:Model

6 Publications found

Proactive therapeutic drug monitoring of adalimumab for pediatric Crohn’s disease patients: A cost-effectiveness analysis.

b

Journal of gastroenterology and hepatology

September 1, 2021

p Therapeutic drug monitoring

c Economics Model
Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s Disease: A Cost-Effectiveness Analysis in a Simulated Cohort.

b

Inflammatory bowel diseases

January 1, 2020

p Therapeutic drug monitoring

c Economics Model
Optimizing the dose in patients treated with imatinib as first line treatment for gastrointestinal stromal tumours: A cost-effectiveness study.

b

British journal of clinical pharmacology

September 1, 2019

p Therapeutic drug monitoring

c Economics Model
Personalised treatment using serum drug levels of adalimumab in patients with rheumatoid arthritis: an evaluation of costs and effects.

b

Annals of the rheumatic diseases

February 1, 2015

p Therapeutic drug monitoring

c Economics Model
Cost savings of anti-TNF therapy using a test-based strategy versus an empirical dose escalation in Crohn’s disease patients who lose response to infliximab.

b

Journal of market access & health policy

January 1, 2015

p Therapeutic drug monitoring

c Economics Model
Cost effectiveness analysis of pharmacokinetically-guided 5-fluorouracil in FOLFOX chemotherapy for metastatic colorectal cancer.

b

Clinical colorectal cancer

December 1, 2014

p Therapeutic drug monitoring

c Economics Model